Explorative study of interleukin levels in the human cornea

Area of Science:

• Ophthalmology
• Immunology
• Corneal Disease Research

Background:

• Interleukins are present in ocular tissues and implicated in corneal inflammatory disorders.
• Pathogenic mechanisms involving interleukins in corneal inflammation are not fully understood.
• This study investigates interleukin-1 beta (IL-1 beta) and interleukin-6 (IL-6) concentrations in human corneas.

Purpose of the Study:

• To analyze the concentrations of IL-1 beta and IL-6 in human corneas.
• To correlate interleukin levels with various clinical diagnoses of corneal diseases.
• To assess the potential of interleukin levels as biomarkers for corneal inflammation.

Main Methods:

• 127 explanted human corneas with diverse corneal diseases were collected post-keratoplasty.
• Corneal tissues were snap-frozen, cryosectioned, and histologically examined.
• Protein content was measured (Bradford method), and IL-1 beta and IL-6 concentrations were determined via ELISA.

Main Results:

• Elevated levels of IL-1 beta and IL-6 were observed in corneas exhibiting ulcerations and significant inflammatory signs.
• Lower concentrations of both interleukins were detected in corneas with minimal inflammatory indicators.
• A clear distinction in interleukin levels was found between inflammatory and non-inflammatory corneal conditions.

Conclusions:

• Higher interleukin levels were associated with inflammatory conditions such as keratitis, inflammatory keratoconus, and ulcerating processes.
• Non-inflammatory corneal disorders, including scars, dystrophies, and non-inflammatory keratoconus, showed lower interleukin levels.
• Corneal interleukin levels can potentially serve as indicators for evaluating the inflammatory status based on clinical diagnosis.